表紙:輸血診断の世界市場:現状分析と予測(2021年~2027年)
市場調査レポート
商品コード
1096538

輸血診断の世界市場:現状分析と予測(2021年~2027年)

Blood Transfusion Diagnostics Market: Current Analysis and Forecast (2021-2027)

出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 212 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
輸血診断の世界市場:現状分析と予測(2021年~2027年)
出版日: 2022年06月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 212 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の輸血診断の市場規模は、予測期間(2021年~2027年)中に約7%のCAGRで成長すると予測されています。

輸血診断市場の成長の主な要因としては、高齢者人口の増加、世界の手術の普及、怪我や外傷の発生率の増加、貧血や白血病、腎臓病などの有病率の急上昇などが挙げられます。また、献血に対する意識の高まりも、市場成長の原動力となると考えられます。

当レポートでは、世界の輸血診断市場について調査しており、市場の洞察、市場の動向、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場のイントロダクション

  • 市場の定義
  • 制限
  • ステークホルダー
  • レポートで使用される通貨

第2章 調査方法または仮定

  • 輸血診断市場の調査プロセス
  • 輸血診断市場の調査手法
  • 予測方法
  • 回答者のプロファイル
  • 輸血診断市場調査の主な目的

第3章 市場の要約

第4章 エグゼクティブサマリー

第5章 輸血診断市場におけるCOVID-19の影響

第6章 輸血診断市場の収益(2019年~2027年)

第7章 市場の洞察:製品タイプ別

  • 試薬とキット
  • 装置

第8章 市場の洞察:アプリケーション別

  • 血液型分類
  • 疾患スクリーニング
    • 血清学的疾患スクリーニング
    • 分子疾患スクリーニング

第9章 市場の洞察:エンドユーザー別

  • 病院
  • 血液バンク
  • 診断研究所
  • その他

第10章 市場の洞察:地域別

  • 北米
    • 米国
    • カナダ
    • その他の北米
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他のアジア太平洋
  • その他

第11章 輸血診断市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第12章 輸血診断市場の機会

第13章 輸血診断市場の動向

第14章 法規制の枠組み

第15章 需要と供給側の分析

  • 需要側分析
  • 供給側分析

第16章 バリューチェーン分析

第17章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第18章 会社概要

  • Immucor Inc.
  • Ortho Clinical Diagnostics
  • Abbott Laboratories
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche AG
  • Quotient Limited
  • BAG Healthcare GmbH
  • DiaSorin S.P.A.
  • Danaher Corporation
  • BIOKIT (Werfen)

第19章 免責事項

目次
Product Code: UMHE21862

Blood transfusion diagnostics is expected to witness a CAGR of around ~7% during the forecast period (2021-2027). The key factors responsible for the growth of the market include the growing geriatric population, increasing prevalence of surgeries worldwide, high rate of injuries and trauma cases, and surging prevalence of anemia, leukemia, or kidney disease. Blood transfusion is usually done as a lifesaving operation to replace blood cells or blood products lost through severe bleeding, blood loss during surgery, or to increase the platelet count in the patient. According to the Community Blood Center, In America, 4.5 million people need blood transfusion each year. According to the World Health Organization (WHO), in low-income countries, up to 54 % of blood transfusions are given to children under 5 years of age, whereas in high-income countries, the most frequently transfused patient group is over 60 years of age, accounting for up to 76% of all transfusions. The rising geriatric population is also expected to drive the growth of the blood transfusion diagnostic market during the forecast period. Moreover, in the APAC region, there is a steady increase in the number of surgeries, accidents, blood donation centers, and blood donors, and a rise in awareness about blood donation will drive the market growth during the forecast period.

Immucor, Inc., Ortho Clinical Diagnostics, Abbott, Bio-Rad Laboratories, F. Hoffmann-La Roche AG, Quotient Limited, BAG Healthcare GmbH, DiaSorin S.P.A., Danaher, and BIO KIT (Werfen) are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products/technologies.

Insights Presented in the Report

"Amongst Product, reagents and kits category accounted for the majority share in the market in 2020"

Based on product type, the blood transfusion diagnostics market is segmented into Reagents & Kits, and Instruments. In 2020, The reagents and kits category held the largest share and is anticipated to witness a considerable growth rate over the forecast period. The availability of technologically advanced donor screening analyzers will drive the growth of this segment. In addition, the rising availability of rapid diagnostic kits for safe blood transfusion is expected to boost the market growth. Furthermore, the rising prevalence of injuries and accidents across the world is also a major factor in the growth of this segment. According to CDC, every year an average of around 6 million car accident cases occurs in the U.S. Among them, approximately 3 million people are injured. Moreover, surgeries such as post-cardiopulmonary bypass, neurosurgery, posterior eye surgery, and chronic bleeding disorders also require platelet transfusions.

"Amongst Application, Disease Screening category is expected to witness highest CAGR during the forecast period"

Based on application type, the blood transfusion diagnostics market has been segmented into blood grouping, and disease screening. In 2020, the Disease Screening category held the largest share and is anticipated to witness a considerable growth rate over the forecast period. This can be due to a high number of transfusion-transmitted infection (TTI) cases, rising safety screening of donated blood, maintaining safe transfusion, rising technological advancements, and wide products offered by key players in the market. For instance, blood transfusion is a base in the treatment of anemic patients. Thus, the growing elderly population with iron deficiency is also supporting the market growth. According to World Health Organization (WHO), Anemia is a serious global public health problem that particularly affects young children and pregnant women. WHO estimates that 42% of children less than 5 years of age and 40% of pregnant women worldwide are anemic.

"Amongst End-User, blood banks category is expected to witness highest CAGR during the forecast period"

Based on end-users, the blood transfusion diagnostics market is segmented into hospitals, blood banks, diagnostic laboratories, and others. In 2020, the blood banks category dominated the blood transfusion diagnostics market and is expected to grow significantly in the upcoming years. The growth of this segment is due to rising surgical procedures, injuries, anemia, leukemia, and kidney failure treatment procedures. However, the blood bank segment is expected to grow in developing nations because of the geriatric population, and the increasing number of road accidents. Also, the increasing awareness of blood donation in developing countries is also one of the prominent factors due to which the blood bank segment is expected is grow in the forecast period.

"North America to witness significant growth during the forecast period"

Geographically, North America is expected to lead the blood transfusion diagnostics market throughout the analysis period. This can be attributed to the greater presence of industry players, high healthcare spending, and increase in research and development (R&D) activities in the region. Furthermore, an increase in the number of surgeries, a rising number of road accidents coupled with a surge in the number of cancer cases such as leukemia, lymphoma, and myeloma. These are some of the drivers of the North American blood transfusion diagnostics market. In addition, according to the Leukemia and Lymphoma Society (LLS), An estimated combined total of 186,400 people in the US are expected to be diagnosed with leukemia, lymphoma, or myeloma in 2021. and new cases of leukemia, lymphoma, and myeloma are expected to account for 9.8 percent of the estimated 1,898,160 new cancer cases that will be diagnosed in the US in 2021. moreover, increasing health awareness, high disposable income, favorable reimbursement policies, and well-established healthcare infrastructure are some of the key factors boosting the regional market.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.

Customization Options:

The blood transfusion diagnostics Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Limitation
  • 1.3. Stake Holders
  • 1.4. Currency used in Report

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Blood Transfusion Diagnostics Market
  • 2.2. Research Methodology of the Blood Transfusion Diagnostics Market
  • 2.3. Forecasting Method
  • 2.4. Respondent Profile
  • 2.5. Main Objective of the Blood Transfusion Diagnostics Market Study

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 BLOOD TRANSFUSION DIAGNOSTICS MARKET COVID-19 IMPACT

6 BLOOD TRANSFUSION DIAGNOSTICS MARKET REVENUE, 2019-2027F

7 MARKET INSIGHTS BY PRODUCT TYPE

  • 7.1. Reagents & Kits
  • 7.2. Instruments

8 MARKET INSIGHTS BY APPLICATION

  • 8.1. Blood Grouping
  • 8.2. Disease Screening
    • 8.2.1. Serological Disease Screening
    • 8.2.2. Molecular Disease Screening

9 MARKET INSIGHTS BY END-USER

  • 9.1. Hospitals
  • 9.2. Blood Banks
  • 9.3. Diagnostic Laboratories
  • 9.4. Others

10 MARKET INSIGHTS BY REGION

  • 10.1. North America
    • 10.1.1. U.S.
    • 10.1.2. Canada
    • 10.1.3. Rest of America
  • 10.2. Europe
    • 10.2.1. Germany
    • 10.2.2. U.K.
    • 10.2.3. France
    • 10.2.4. Spain
    • 10.2.5. Italy
    • 10.2.6. Rest of Europe
  • 10.3. Asia-Pacific
    • 10.3.1. China
    • 10.3.2. India
    • 10.3.3. Japan
    • 10.3.4. Australia
    • 10.3.5. Rest of Asia-Pacific
  • 10.4. Rest of the World

11 BLOOD TRANSFUSION DIAGNOSTICS MARKET DYNAMICS

  • 11.1. Market Drivers
  • 11.2. Market Challenges
  • 11.3. Impact Analysis

12 BLOOD TRANSFUSION DIAGNOSTICS MARKET OPPORTUNITIES

13 BLOOD TRANSFUSION DIAGNOSTICS MARKET TRENDS

14 LEGAL & REGULATORY FRAMEWORK

15 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 15.1. Demand Side Analysis
  • 15.2. Supply Side Analysis

16 VALUE CHAIN ANALYSIS

17 COMPETITIVE SCENARIO

  • 17.1. Competitive Landscape
    • 17.1.1. Porter's Five Forces Analysis

18 COMPANY PROFILED

  • 18.1. Immucor Inc.
  • 18.2. Ortho Clinical Diagnostics
  • 18.3. Abbott Laboratories
  • 18.4. Bio-Rad Laboratories
  • 18.5. F. Hoffmann-La Roche AG
  • 18.6. Quotient Limited
  • 18.7. BAG Healthcare GmbH
  • 18.8. DiaSorin S.P.A.
  • 18.9. Danaher Corporation
  • 18.10. BIOKIT (Werfen)

19 DISCLAIMER